BBA
CRDF icon

Baader Bank Aktiengesellschaft’s Cardiff Oncology CRDF Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,022
Closed -$19.5K – 516
2025
Q2 		$19.5K Buy
+10,022
New +$30.6K ﹤0.01% 414

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baader Bank Aktiengesellschaft's CRDF Position: Q3 2025 in Review

Baader Bank Aktiengesellschaft sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 10,022 shares — an estimated $19.5K sold.

Baader Bank Aktiengesellschaft first reported a position in CRDF in Q2 2025 and held it in 1 quarter. The position peaked at $19.5K in Q2 2025. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Baader Bank Aktiengesellschaft reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 10,022 Cardiff Oncology shares in Q3 2025, an estimated $19.5K.
  • Baader Bank Aktiengesellschaft first reported a position in Cardiff Oncology in Q2 2025 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Cardiff Oncology position peaked at $19.5K in Q2 2025.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2025, filed 6 Nov 2025.